What Is the Optimal Treatment for Vulnerable Older Women With Ovarian Cancer?-Reply

التفاصيل البيبلوغرافية
العنوان: What Is the Optimal Treatment for Vulnerable Older Women With Ovarian Cancer?-Reply
المؤلفون: Gilles Freyer, Claire Falandry, Eric Pujade-Lauraine
المساهمون: CarMeN, laboratoire, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Groupe d'Investigateurs Nationaux pour l'Étude des Cancers de l'Ovaire et du sein [Paris] (GINECO), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), ARCAGY-GINECO, Université Paris Descartes - Paris 5 (UPD5)
المصدر: JAMA oncology
JAMA oncology, American Medical Association, 2021, 7 (11), pp.1727. ⟨10.1001/jamaoncol.2021.4131⟩
بيانات النشر: HAL CCSD, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Ovarian Neoplasms, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Optimal treatment, [SDV]Life Sciences [q-bio], Carcinoma, Ovarian Epithelial, medicine.disease, [SDV] Life Sciences [q-bio], Internal medicine, Humans, Medicine, Female, business, Ovarian cancer, ComputingMilieux_MISCELLANEOUS, Aged
الوصف: International audience; No abstract available
اللغة: English
تدمد: 2374-2437
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf5471f511b32bddb063bd1bc235743aTest
https://www.hal.inserm.fr/inserm-03587199Test
رقم الانضمام: edsair.doi.dedup.....bf5471f511b32bddb063bd1bc235743a
قاعدة البيانات: OpenAIRE